
Latest
High medicine costs and supply gaps limit treatment access in developing countries
The 2026 Access to Medicine Index highlights persistent inequalities in access to essential medicines, particularly cancer and diabetes treatments, despite progress by leading pharmaceutical companies in developing strategies to reach underserved populations.
View all stories










































